University of North Carolina, Chapel Hill: Communicable Diseases trials

The registry lists 24 Communicable Diseases studies with University of North Carolina, Chapel Hill as lead sponsor. 0 are open to participants now and 13 have results posted.

Phase 1 2Phase 2 4Phase 4 3No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Love Infection: A Dramatized Story Intervention (Telenovela/Soap Opera) for HIV PreventionCompletedNCT05358366Not applicableResults posted
• Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)CompletedNCT05178173Not applicableResults posted
• Friendship Bench Adaptation to Improve Mental Health & HIV Care Engagement Outcomes Among PLWH and PWID in VietnamCompletedNCT04790201Not applicableResults posted
• Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19TerminatedNCT04748783Phase 2Results posted
• Uptake of Medical Male Circumcision Among Men With Sexually Transmitted InfectionsCompletedNCT04677374Not applicableResults posted
• Mouth Rinses for Inactivation of COVID-19TerminatedNCT04584684Phase 2Results posted
• Arresting Vertical Transmission of Hepatitis B VirusCompletedNCT03567382Phase 4Results posted
• Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)CompletedNCT03212989Phase 1Results posted
• Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV InfectionCompletedNCT02384395Not applicableResults posted
• Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV InfectionCompletedNCT00959894Phase 2Results posted
• Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)CompletedNCT00924898Phase 4Results posted
• HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and EtravirineTerminatedNCT00855413Phase 4Results posted
• MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV InfectionTerminatedNCT00614458Phase 2Results posted
• Integrating Enhanced HIV PrEP Into a STI Clinic in LilongweCompletedNCT05307991
• RBG: Regular, Bare, Gel: Does Type of Nail Polish Affect Bacterial Counts After Surgical Scrubbing?CompletedNCT05210920Not applicable
• ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19CompletedNCT04367740
• Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South AfricaCompletedNCT04205721Not applicable
• Community-associated Highly-Resistant EnterobacteralesCompletedNCT03924934
• Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 InfectionTerminatedNCT02707900Phase 1
• Acute Partner and Social Contact Referral: iKnowCompletedNCT02467439Not applicable
• Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human VolunteersCompletedNCT02019745
• Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIVCompletedNCT01492842
• Efficacy of Caterpillar Cereal for Complementary Feeding in the Democratic Republic of CongoCompletedNCT01282788Not applicable
• Vitamin D Reabsorption in Adolescents and Young Adults With HIV InfectionCompletedNCT00490412Not applicable